Veradermics, Incorporated MANE 深 滬
等待開盤 03-26 09:30:00 美东时间
65.56
+2.070
+3.26%
華盛通- 最 高66.54
- 今 開63.65
- 成交量 46.72万股
- 最 低 62.28
- 昨 收 63.49
- 總市值 24.48亿
- 52周最高 66.54
- 市盈率 靜 --
- 換手率 1.25%
- 52周最低 32.00
- 委 比 0.00%
- 總股本 3733.87万
- 歷史最高 66.54
- 量 比 0.70
- 振 幅 6.71%
- 歷史最低 32.00
- 每 手 1
- 風險率 8.75%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Veradermics to present three VDPHL01 and hair-loss patient experience abstracts at AAD annual meeting
Veradermics to present three VDPHL01 and hair-loss patient experience abstracts at AAD annual meeting Veradermics said three abstracts will be presented at the American Academy of Dermatology Annual Meeting in Denver, Colorado, on March 27-31, 2026. Two social listening presentations are scheduled f
03-18 19:00
美股大行评级 | 花旗：维持康菲石油"买入"评级！目标价从125美元升至135美元
今日重点评级关注：HC Wainwright & Co.：维持Helus Pharma"买入"评级，目标价从55美元升至95美元；HC Wainwright & Co.：维持Compass Pathways"买入"评级，目标价从40美元升至70美元
03-03 20:22
Veradermics to Participate in Upcoming March Investor Conferences
Veradermics to Participate in Upcoming March Investor Conferences Veradermics Inc. (NYSE: MANE) will participate in two investor conferences in Miami, Florida: the Leerink Partners Global Healthcare Conference on Tuesday, March 10 (including a 4:20 p.m. ET fireside chat with CEO Reid Waldman, M.D.)
03-03 20:01
Jefferies Initiates Coverage On Veradermics with Buy Rating, Announces Price Target of $75
Jefferies analyst Roger Song initiates coverage on Veradermics (NYSE:MANE) with a Buy rating and announces Price Target of $75.
03-02 21:04
U.S. RESEARCH ROUNDUP-Aardvark Therapeutics, Chevron, Crowdstrike
U.S. RESEARCH ROUNDUP-Aardvark Therapeutics, Chevron, Crowdstrike March 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aardvark Therapeutics, Chevron and Crowdstrike, on Monday. HIGHLIGHTS * Aardvark Therapeutics Inc
03-02 15:29
今年2月，全球共15家创新药公司完成超5000万美元融资
据药明康德（603259.SH）公众号消息，根据药明康德数据库统计，截至2026年2月27日，2026年2月全球生物医药领域共计完成94起融资活动，累计公开披露...
02-28 08:43
UPDATE 2-Flagship-backed Generate Biomedicines eyes $2.2 billion valuation in US IPO
UPDATE 2-Flagship-backed Generate Biomedicines eyes $2.2 billion valuation in US IPO Adds background and details in paragraphs 4-7 Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion its initial public offering in the United Stat
02-23 19:54
生物制药公司VeraDermics补办上市仪式：市值15亿美元 治疗脱发
雷递网 雷建平 2月15日 专注于皮肤病领域的生物制药公司VeraDermics(NYSE:MANE)日前在美股上市，发行价为17美元，发行1508万股，募资总...
02-15 16:24
美股长牛关键催化震撼来袭! SpaceX与OpenAI等巨头蓄势待发 高盛押注2026年乃IPO大年
美国首次公开募股（IPO）有望在今年大幅反弹，这得益于稳健的经济环境、不断增强的董事会信心和支持性的货币政策等利好因素。预计到 2026 年，筹资规模将达到1600 亿美元，交易数量预计将增至 120 笔，比去年的交易数量几乎翻番。
02-10 10:23
美股周涨跌榜 | 光通信龙头Lumentum业绩炸裂！周内飙涨逾40%；创新药公司MANE上市股价即翻倍
光通信龙头Lumentum业绩炸裂！周内股价飙涨逾40%；创新药公司MANE上市即翻倍，聚焦脱发口服药物；德州仪器75亿美元收编芯科实验室>>
02-07 11:39
